Introduction: The search for an HIV cure involves important behavioural and social processes
that complement the domains of biomedicine. However, the field has yet to tap into the full …

Women remain underrepresented in HIV research. The AIDS Clinical Trials Group (ACTG)
5366 study was the first HIV cure-related trial conducted exclusively in women. Our …

Introduction Participation in early-phase HIV cure studies includes clinical risks with little to
no likelihood of clinical benefit. Examining the willingness of people living with HIV to …

Developing a cure for HIV is a global priority. Target product profiles are a tool commonly used
throughout the drug development process to align interested parties around a clear set of …

Analytical antiretroviral treatment interruption (ATI) is an important feature of HIV research,
seeking to achieve sustained viral suppression in the absence of antiretroviral therapy (ART) …

Introduction Biomedical research towards an HIV cure is advancing in the United States and
elsewhere, yet little is known about perceptions of risks and benefits among potential study …

The quest for a cure for HIV remains a timely and key challenge for the HIV research community.
Despite significant scientific advances, current HIV therapy regimens do not completely …

It is clear that early ART has a greater impact in limiting the HIV reservoirs than later treatment.
However, latently infected long-lived memory CD4+ T cells persist in most early treated …

Strategies to control HIV in the absence of antiretroviral therapy are needed to cure HIV.
However, such strategies will require analytical treatment interruptions (ATIs) to determine their …

Over the past several years there has been intense activity directed at the possibility of
achieving remission or eradication of HIV infection. Current assays for the measurement of latent …